Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells

17Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

The present study aims to investigate the role of p73 in response to cisplatin treatment in p53 wild-type neuroblastoma SH-SY5Y cells. Results showed that cisplatin induced a dose-dependent up-regulation of p53, p73, and a number of p53-responsive genes. Interestingly, endogenous Δexon2p73-expression was down-regulated by cisplatin treatment. Neither p21 nor GADD45 induction was observed in p53-deficient Lan-1 cells, although endogenous TAp73 expression was markedly induced. In the presence of cisplatin, exogenous TAp73 overexpression in SH-SY5Y cells induced p21 upregulation without altering the apoptotic sub-G1 cell population. Moreover, siRNA-mediated suppression of TAp73 expression did not alter the sub-G1 population. Collectively, our results suggest that wt-p53 SH-SY5Y cells respond to cisplatin by inducing p73 isoform regulation and sustaining p53-dependent apoptosis that is independent of TAp73α.

Author supplied keywords

Cite

CITATION STYLE

APA

Million, K., Horvilleur, É., Goldschneider, D., Agina, M., Raguénez, G., Tournier, F., … Douc-Rasy, S. (2006). Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells. International Journal of Oncology, 29(1), 147–154. https://doi.org/10.3892/ijo.29.1.147

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free